Please rotate your device to landscape mode.

Menu

1

2

#OpenInnovation

3

4

News & Events

mRNA Disruptor Goes Public in $1.5 Billion SPAC Deal

August 10, 2021

Messenger RNA has become the life sciences hero of the decade. Read more

InterVenn Biosciences Raises $201 Million

August 2, 2021

Series C financing for AI-driven Glycoproteomic Platform, Liquid-Biopsy development. Read more

Khazanah-backed Rapid Micro Biosystems listed on Nasdaq

July 22, 2021

IPO of 7.92 million shares at US$20 each to raise US$158.4 million (about RM669.76 million). Read more

5

#knowledgebase

6

7

News & Events

mRNA Disruptor Goes Public in $1.5 Billion SPAC Deal

August 10, 2021

Messenger RNA has become the life sciences hero of the decade. Read more

InterVenn Biosciences Raises $201 Million

August 2, 2021

Series C financing for AI-driven Glycoproteomic Platform, Liquid-Biopsy development. Read more

Khazanah-backed Rapid Micro Biosystems listed on Nasdaq

July 22, 2021

IPO of 7.92 million shares at US$20 each to raise US$158.4 million (about RM669.76 million). Read more

8

Portfolio Highlights

#PharmaBiotech

9

Portfolio Highlights

#MedTech

11

Our View

10

Our Focus

12

#PRI

22

Medical Technologies
#Portfolio

14

16

Words from
the CEO

17

Portfolio Highlights

#PharmaBiotech

28

Pharmaceutical Biotech
#Portfolio

15

About Us

34

Biorenewables & Others
#Portfolio

19

WHAT'S TRENDING @ XERAYA

Greenlight Biosciences $1.5b SPAC Deal

20

Our Team

21

13

Partnership

#corevalues

23

Portfolio Highlights

#Biorenewables

30

Portfolio Highlights

#MedTech

18

Integrity

#corevalues

25

26

ARE YOU
The Next
Big Thing?

Submit
A Proposal

27

Portfolio Highlights

#MedTech

24

Responsibility

#corevalues

29

36

Career

#Xeraya

35

37

News & Events

mRNA Disruptor Goes Public in $1.5 Billion SPAC Deal

August 10, 2021

Messenger RNA has become the life sciences hero of the decade. Read more

InterVenn Biosciences Raises $201 Million

August 2, 2021

Series C financing for AI-driven Glycoproteomic Platform, Liquid-Biopsy development. Read more

Khazanah-backed Rapid Micro Biosystems listed on Nasdaq

July 22, 2021

IPO of 7.92 million shares at US$20 each to raise US$158.4 million (about RM669.76 million). Read more

32

#agro

33

Portfolio Highlights

#Biorenewables

38

Portfolio Highlights

#MedTech

39

40

Contact Us

41